1,3-OXATIOLANOS UTILES EN EL TRATAMIENTO DE LA HEPATITIS
LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DE ANALOGOS NUCLEOSIDOS EN EL TRATAMIENTO DE INFECCIONES VIRICAS. MAS ESPECIFICAMENTE SE OCUPA DE LA UTILIZACION DE ANALOGOS NUCLEOSIDOS DE 1,3-OXATIOLANO EN EL TRATAMIENTO DE HEPATITIS, EN PARTICULAR HEPATITIS B. The present invention relates to the...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | NGUYEN-BA, NGHE BELLEAU, BERNARD |
| description | LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DE ANALOGOS NUCLEOSIDOS EN EL TRATAMIENTO DE INFECCIONES VIRICAS. MAS ESPECIFICAMENTE SE OCUPA DE LA UTILIZACION DE ANALOGOS NUCLEOSIDOS DE 1,3-OXATIOLANO EN EL TRATAMIENTO DE HEPATITIS, EN PARTICULAR HEPATITIS B.
The present invention relates to the use of nucleoside analogues in the treatment of viral infections. More specifically it is concerned with the use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis, in particular hepatitis B. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2270413TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2270413TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2270413TT33</originalsourceid><addsrcrecordid>eNrjZLAw1DHW9Y9wDPH093H08w9WCA3x9HENVnD1U3D1UQgJcgxx9PV09QvxV3BxVfBxVPBwDQCqDfEM5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8a7BRkbmBiaGxiEhxsbEqAEAOokoeA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>1,3-OXATIOLANOS UTILES EN EL TRATAMIENTO DE LA HEPATITIS</title><source>esp@cenet</source><creator>NGUYEN-BA, NGHE ; BELLEAU, BERNARD</creator><creatorcontrib>NGUYEN-BA, NGHE ; BELLEAU, BERNARD</creatorcontrib><description>LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DE ANALOGOS NUCLEOSIDOS EN EL TRATAMIENTO DE INFECCIONES VIRICAS. MAS ESPECIFICAMENTE SE OCUPA DE LA UTILIZACION DE ANALOGOS NUCLEOSIDOS DE 1,3-OXATIOLANO EN EL TRATAMIENTO DE HEPATITIS, EN PARTICULAR HEPATITIS B.
The present invention relates to the use of nucleoside analogues in the treatment of viral infections. More specifically it is concerned with the use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis, in particular hepatitis B.</description><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070401&DB=EPODOC&CC=ES&NR=2270413T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070401&DB=EPODOC&CC=ES&NR=2270413T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NGUYEN-BA, NGHE</creatorcontrib><creatorcontrib>BELLEAU, BERNARD</creatorcontrib><title>1,3-OXATIOLANOS UTILES EN EL TRATAMIENTO DE LA HEPATITIS</title><description>LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DE ANALOGOS NUCLEOSIDOS EN EL TRATAMIENTO DE INFECCIONES VIRICAS. MAS ESPECIFICAMENTE SE OCUPA DE LA UTILIZACION DE ANALOGOS NUCLEOSIDOS DE 1,3-OXATIOLANO EN EL TRATAMIENTO DE HEPATITIS, EN PARTICULAR HEPATITIS B.
The present invention relates to the use of nucleoside analogues in the treatment of viral infections. More specifically it is concerned with the use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis, in particular hepatitis B.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAw1DHW9Y9wDPH093H08w9WCA3x9HENVnD1U3D1UQgJcgxx9PV09QvxV3BxVfBxVPBwDQCqDfEM5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8a7BRkbmBiaGxiEhxsbEqAEAOokoeA</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>NGUYEN-BA, NGHE</creator><creator>BELLEAU, BERNARD</creator><scope>EVB</scope></search><sort><creationdate>20070401</creationdate><title>1,3-OXATIOLANOS UTILES EN EL TRATAMIENTO DE LA HEPATITIS</title><author>NGUYEN-BA, NGHE ; BELLEAU, BERNARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2270413TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NGUYEN-BA, NGHE</creatorcontrib><creatorcontrib>BELLEAU, BERNARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NGUYEN-BA, NGHE</au><au>BELLEAU, BERNARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>1,3-OXATIOLANOS UTILES EN EL TRATAMIENTO DE LA HEPATITIS</title><date>2007-04-01</date><risdate>2007</risdate><abstract>LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DE ANALOGOS NUCLEOSIDOS EN EL TRATAMIENTO DE INFECCIONES VIRICAS. MAS ESPECIFICAMENTE SE OCUPA DE LA UTILIZACION DE ANALOGOS NUCLEOSIDOS DE 1,3-OXATIOLANO EN EL TRATAMIENTO DE HEPATITIS, EN PARTICULAR HEPATITIS B.
The present invention relates to the use of nucleoside analogues in the treatment of viral infections. More specifically it is concerned with the use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis, in particular hepatitis B.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2270413TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 1,3-OXATIOLANOS UTILES EN EL TRATAMIENTO DE LA HEPATITIS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T21%3A59%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NGUYEN-BA,%20NGHE&rft.date=2007-04-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2270413TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |